Keywords: Sunovion, Dainippon Sumitomo, Elevation Pharma, EP-101, COPD

Sunovion to acquire Elevation Pharma for up to $430 million

Article | 03 September 2012

Print This

Sunovion Pharmaceuticals, a US subsidiary of Japan’s Dainippon Sumitomo Pharma (TYO: 4506) last week signed a definitive agreement to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in